Cargando…

Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges

The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degene...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjivassiliou, Marios, Manto, Mario, Mitoma, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496914/
https://www.ncbi.nlm.nih.gov/pubmed/36138901
http://dx.doi.org/10.3390/brainsci12091165
_version_ 1784794388032913408
author Hadjivassiliou, Marios
Manto, Mario
Mitoma, Hiroshi
author_facet Hadjivassiliou, Marios
Manto, Mario
Mitoma, Hiroshi
author_sort Hadjivassiliou, Marios
collection PubMed
description The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Apart from these well-established entities, cerebellar ataxia (CA) occurs also in association with autoimmunity against ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, glial cells, as well as the brainstem antigens. Most of these conditions manifest diverse neurological clinical features, with CAs being one of the main clinical phenotypes. The term primary autoimmune cerebellar ataxia (PACA) refers to ataxic conditions suspected to be autoimmune even in the absence of specific well-characterized pathogenic antibody markers. We review advances in the field of IMCAs and propose a clinical approach for the understanding and diagnosis of IMCAs, focusing on rare etiologies which are likely underdiagnosed. The frontiers of PACA are discussed. The identification of rare immune ataxias is of importance since they are potentially treatable and may lead to a severe clinical syndrome in absence of early therapy.
format Online
Article
Text
id pubmed-9496914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94969142022-09-23 Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges Hadjivassiliou, Marios Manto, Mario Mitoma, Hiroshi Brain Sci Review The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Apart from these well-established entities, cerebellar ataxia (CA) occurs also in association with autoimmunity against ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, glial cells, as well as the brainstem antigens. Most of these conditions manifest diverse neurological clinical features, with CAs being one of the main clinical phenotypes. The term primary autoimmune cerebellar ataxia (PACA) refers to ataxic conditions suspected to be autoimmune even in the absence of specific well-characterized pathogenic antibody markers. We review advances in the field of IMCAs and propose a clinical approach for the understanding and diagnosis of IMCAs, focusing on rare etiologies which are likely underdiagnosed. The frontiers of PACA are discussed. The identification of rare immune ataxias is of importance since they are potentially treatable and may lead to a severe clinical syndrome in absence of early therapy. MDPI 2022-08-30 /pmc/articles/PMC9496914/ /pubmed/36138901 http://dx.doi.org/10.3390/brainsci12091165 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hadjivassiliou, Marios
Manto, Mario
Mitoma, Hiroshi
Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
title Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
title_full Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
title_fullStr Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
title_full_unstemmed Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
title_short Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
title_sort rare etiologies in immune-mediated cerebellar ataxias: diagnostic challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496914/
https://www.ncbi.nlm.nih.gov/pubmed/36138901
http://dx.doi.org/10.3390/brainsci12091165
work_keys_str_mv AT hadjivassilioumarios rareetiologiesinimmunemediatedcerebellarataxiasdiagnosticchallenges
AT mantomario rareetiologiesinimmunemediatedcerebellarataxiasdiagnosticchallenges
AT mitomahiroshi rareetiologiesinimmunemediatedcerebellarataxiasdiagnosticchallenges